BPG is committed to discovery and dissemination of knowledge
Articles Published Processes
12/27/2024 1:37:06 PM | Browse: 39 | Download: 142
 |
Received |
|
2024-07-29 14:19 |
 |
Peer-Review Started |
|
2024-07-29 14:19 |
 |
To Make the First Decision |
|
|
 |
Return for Revision |
|
2024-09-10 02:38 |
 |
Revised |
|
2024-09-23 11:51 |
 |
Second Decision |
|
2024-10-28 02:40 |
 |
Accepted by Journal Editor-in-Chief |
|
|
 |
Accepted by Executive Editor-in-Chief |
|
2024-10-28 06:31 |
 |
Articles in Press |
|
2024-10-28 06:31 |
 |
Publication Fee Transferred |
|
2024-10-31 14:40 |
 |
Edit the Manuscript by Language Editor |
|
|
 |
Typeset the Manuscript |
|
2024-11-06 08:10 |
 |
Publish the Manuscript Online |
|
2024-12-27 13:37 |
ISSN |
1948-9366 (online) |
Open Access |
This article is an open-access article that was selected by an in-house editor and fully peer-reviewed by external reviewers. It is distributed in accordance with the Creative Commons Attribution NonCommercial (CC BY-NC 4.0) license, which permits others to distribute, remix, adapt, build upon this work non-commercially, and license their derivative works on different terms, provided the original work is properly cited and the use is non-commercial. See: http://creativecommons.org/Licenses/by-nc/4.0/ |
Copyright |
© The Author(s) 2024. Published by Baishideng Publishing Group Inc. All rights reserved. |
Article Reprints |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/247
|
Permissions |
For details, please visit: http://www.wjgnet.com/bpg/gerinfo/207
|
Publisher |
Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA |
Website |
http://www.wjgnet.com |
Category |
Infectious Diseases |
Manuscript Type |
Case Report |
Article Title |
Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report
|
Manuscript Source |
Unsolicited Manuscript |
All Author List |
Xiao-Qin Zheng, Li-Bo Sun, Wen-Jie Jin, Hui Liu, Wen-Yan Song, Hui Xu, Ju-Shan Wu, Xiao-Jun Wang, Chun-Yan Gou and Hui-Guo Ding |
ORCID |
|
Funding Agency and Grant Number |
|
Corresponding Author |
Hui-Guo Ding, Department of Gastroenterology and Hepatology, Beijing Youan Hospital, Capital Medical University, No. 8 Xitoutiao, Youanmenwai, Fengtai District, Beijing 100069, China. dinghuiguo@ccmu.edu.cn |
Key Words |
Hepatectomy; Sorafenib; Camrelizumab; Super-giant hepatocellular carcinoma; Complete remission; Case report |
Core Tip |
Cirrhotic patients with super-giant hepatocellular carcinoma (HCC), accompanied by portal vein invasion, generally have a poor prognosis. We report a patient with super-giant HCC and portal vein invasion, who underwent hepatectomy followed by sorafenib plus camrelizumab, resulting in complete remission for 5 years. However, two critical issues are raised: One is how to screen and manage portal hypertension in HCC, and the other is related to the optimal treatment duration of tyrosine kinase inhibitors and immune checkpoint inhibitors in HCC patients who achieve complete remission. Further research is needed to address these challenges. |
Publish Date |
2024-12-27 13:37 |
Citation |
<p>Zheng XQ, Sun LB, Jin WJ, Liu H, Song WY, Xu H, Wu JS, Wang XJ, Gou CY, Ding HG. Five-year complete remission of super-giant hepatocellular carcinoma with hepatectomy followed by sorafenib plus camrelizumab: A case report. <i>World J Gastrointest Surg</i> 2025; 17(1): 99752</p> |
URL |
https://www.wjgnet.com/1948-9366/full/v17/i1/99752.htm |
DOI |
https://dx.doi.org/10.4240/wjgs.v17.i1.99752 |
© 2004-2025 Baishideng Publishing Group Inc. All rights reserved. 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA
California Corporate Number: 3537345